Concepedia
Statistics
Publications
5
Citations
210
H-Index
Active since
2019
Affiliations
Polyphor (Switzerland)(Current)
Philip Barth is an author at Polyphor (Switzerland).
Publications per year
2019–2022
Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis
Keith S. Kaye, Adam Belley, Philip Barth et al. · JAMA · 2022 · 94 citations · Full text
Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis
Philip Barth, P. L. B. Bruijnzeel, Achim Wach et al. · Journal of Cystic Fibrosis · 2019 · 46 citations · Full text
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia
Shampa Das, Richard J. Fitzgerald, Asad Ullah et al. · Antimicrobial Agents and Chemotherapy · 2020 · 32 citations · Full text
Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
Holly R. Keir, Christopher J. Fong, Megan Crichton et al. · ERJ Open Research · 2019 · 28 citations · Full text
Market Development for African Endogenous Products
Falylath Babah Daouda, Philip Barth, P.T.M. Ingenbleek · Journal of Macromarketing · 2019 · 10 citations · Full text
1–5 of 5